Disclosures. Goals. Rheumatology Review for Primary Care. No commercial disclosures. We will be discussing non-fda approved uses for some medications.
|
|
- Lorena Perkins
- 5 years ago
- Views:
Transcription
1 Rheumatology Review for Primary Care April 27, 2018 MONA Coming Together in Advanced Practice Disclosures No commercial disclosures. We will be discussing non-fda approved uses for some medications. Goals A general review of some of the most common rheumatic diseases how to identify them, how they are treated. Knowledge of when to refer such patients to rheumatology. 1
2 Objectives Better understanding on what to expect or how to manage the patient on immunosuppressive medications. Gout A crystalline arthropathy caused by overproduction or underexcretion of urate and an increased total body urate pool. Multiple genetic and metabolic factors lead to hyperuricemia top conditions to consider include myeloproliferative disorders, psoriasis, decreased renal function, metabolic syndrome or DMII, diuretic use, alcohol (especially beer) consumption. Gout Gout is a predominantly male disease, at least in younger ages, after women go through menopause, rates approach that of males. Onset is often mid-life, but in men, especially with family history or multiple risk factors, it can be in the 20's. Hyperuricemia is defined as having a uric acid level >7.0 mg/dl, as many as 5% of normal population may have this. 2
3 Gout The most common early presentation is sudden onset severe monoarthritis often 1 st MTP, but tarsal joints common too. Maximal increase in symptoms over 1 day Swelling, redness, heat around joint Resolves in a week with or without treatment This is the acute intermittent phase Gout The typical pattern is to see these attacks happen perhaps a few times a year for a time, then increase in frequency. Treatment for acute flares can include Indomethacin 50mg tid, or oral corticosteroids typically prednisone, given in a 2-3 week taper down from mg (depending on size of joint involved) Colchicine is no longer recommended as treatment for acute gouty flares. Gout To prevent progression of gout to resistant, polyarticular, tophaceous gout, prophylactic treatment is recommended, especially if lifestyle changes (cessation of alcohol abuse, weight reduction, stopping thiazide diuretics) are ineffective or not an option. Conventional purine-restricted diets are only modestly effective in lowering sodium urate. One caveat limiting beer consumption. 3
4 Gout Traditional prophylactic medication is allopurinol typically initiated if the patient has more than 3 gouty attacks per year or is showing signs of developing tophi. Recommended starting dose is 100mg daily, possibly higher if patient is young with good renal function. The dose is increased slowly every couple of weeks as directed by the serum uric acid level. Goal: 6mg/dl or lower. If tophaceous: <5 Gout Allopurinol is approved by FDA at doses up to 800mg/dl! However, most of the time doses are maxed out at 300mg. If one has creatinine clearance >60mg/dl, the increases should be slower, increasing by 50mg as opposed to 100, and newer studies are suggesting that this is well tolerated and improves the numbers of patients able to reach target uric acid levels Gout #1 thing to remember with allopurinol: Do not start or stop without prophylactic med to prevent flare! When initiating allopurinol or increasing dose, patients require 7-10 days of colchicine 0.6mg bid or indomethacin 50mg tid or prednisone 10mg daily. It is felt the change in uric acid levels destabilizes urate crystal deposition in the synovium and this triggers the flare. 4
5 Gout This also means that allopurinol must be dosed daily to prevent flare. It should not be stopped when a flare occurs (worsens severity), and if one misses a dose, might consider prophylaxis for a few days. Uloric (febuxostat) might also be considered, it can lower uric acid considerably, more expensive, only 2 doses. Same prophylaxis with starting and stopping. Gout Probenecid is another medication to lower uric acid, it increases renal excretion. Can only be used in those with >60mg/dl creatinine clearance and who can drink 2L of fluid daily to prevent development of kidney stones. Other measures reducing/stopping diuretic use, losartan, fenofibrate, and atorvastatin all have minor urate reduction properties. Gout When to Refer Recalcitrant flares they don't respond to a 3-4 week prednisone taper or come back as soon as the steroid is stopped. Tophaceous gout development of tophi indicates a more aggressive form of gout has developed. Polyarticular gout instead of a monoarthritis, patients have flares in multiple joints at once. 5
6 Rheumatoid Arthritis The most common autoimmune arthritis still incidence is 0.5 persons per 1000 per year in the US. 1-2% prevalence overall, up to 5% in females by age 70. Females 2.5x more likely to develop than males most common onset in 4-5 th decades of life. Typical onset is insidious increasing joint stiffness, pain, fatigue, over weeks to months. RA Most commonly affected joints MCP's, PIP's of hands, wrists, MTP's of feet symmetrically changes to include elbows, shoulders, knees, ankles over time. PIP's and lumbar spine almost always spared. Morning stiffness >1 hour. 70% with positive rheumatoid factor or anti cyclic citrullinated peptide (anti-ccp) antibody RA Goals in managing RA include reduction in pain and improvement in function, but long term goals are to prevent joint destruction/disability and reduce cardiovascular risk. Treatments typically include corticosteroids for the initial phases, with escalation to use of Disease Modifying Anti-Rheumatic Drugs (DMARD's) and Biologic therapies. NSAID use has been relegated to only occasional/additional. 6
7 RA Goals in managing RA include reduction in pain and improvement in function, but long term goals are to prevent joint destruction/disability and reduce cardiovascular risk. Treatments typically include corticosteroids for the initial phases, with escalation to use of Disease Modifying Anti-Rheumatic Drugs (DMARD's) and Biologic therapies. NSAID use has been relegated to only occasional/additional. RA Corticosteroids can be needed for first year of therapy until good response to DMARD's, sometimes 5mg or less used long term in addition to other meds. DMARDS Hydroxychloroquine, Methotrexate, Leflunomide, Sulfasalazine, Minocycline. All require lab monitoring at least q 12 weeks (except HCQ, which requires annual eye exam). RA Liver dysfunction, bone marrow suppression are main concerns with long-term use. Minor risk for increased infections safe to give live attenuated vaccines. Yearly flu vax recommended, pneumonia vaccines as per age recommendations. Consider holding MTX x 2 weeks after vaccine for best antibody response, if arthritis is very stable. 7
8 RA Biologic meds increased risk for infections, especially in COPD patients. If an antibiotic is prescribed, biologic should be held for best immune response. Minimal increased risk for cancer make sure screening UTD. Anti-TNF alpha meds should be used with caution in those with CHF, worsening symptoms should be reported to rheumatology. RA Associated conditions to consider: Osteporosis corticosteroid induced, also risk higher in RA overall Lung involvement up to 30% of RA patients will have some form nodules or insterstitial lung disease. Secondary Fibromyalgia RA When to Refer New onset symmetric small joint pain/swelling with MS>1 hour, positive RF or anti-ccp antibody, or recurrent episodes of mono or oligoarthritis. Known RA patient who is having multiple infections, new SOB or rashes Known RA patient with new lab abnormalities transaminitis, neutropenia, thrombocytopenia, anemia 8
9 Systemic Lupus Erythematosus (SLE) A highly diverse constellation of signs and symptoms classified as one autoimmune entity. Multiple levels of severity, progression, and system involvement. Predominantly female, young, with strong minority representation (Black and Hispanic). Onset typically after puberty. SLE SLE American College of Rheumatology Diagnostic Criteria-- defines 11 different criteria of which four must be present for diagnosis. Most commonly affected systems include mucocutaneous, musculoskeletal,renal, hematologic and CNS. Despite specifically treating these areas, the most common reason for mortality is accelerated atherosclerosis. 9
10 SLE Symptoms of note photosensitive rash, persistent proteinuria, small joint arthralgias/arthritis, recurrent pleural or pericardial effusions/itis. Treatments: Also variable, but all SLE patients should be on hydroxychloroquine, as it has been shown to reduce progression and flares. Imuran and Methotrexate often used, and Cellcept and IV cytoxan are the meds of choice for renal involvement. SLE Rituximab is being used more and more for severe manifestations. Benlysta newest FDA approved med for SLE can't be used with nephritis or severe manifestations. Infusions takes a long time to onst of benefit. Still not widely used. Corticosteroids. A cornerstone to initiation of treatment, goal is always to reduce/wean off if possible. SLE Recommendations for primary providers of SLE patients please encourage them to take their meds and keep f/u with rheum. Immunosuppression may be more need for frequent antibiotic use don't need to hold HCQ or pred with tx infections, but may temporarily hold imuran or MTX for best immune response. Encourage good photoprotection. 10
11 SLE When to Refer You discover significant proteinuria on UA in absence of infection. Classic photosensitive rashes. Systemic symptoms fevers, weight loss, profound fatigue, arthritis/arthralgias Positive DS-DNA antibody, positive Ro/La, RNP or positive Smith antibody on ANA profile. Psoriatic Arthritis (PsA) Inflammatory arthritis associated with psoriasis. Up to one-third of psoriasis patients can develop PsA. Seen equally in men and women, distribution of joints slightly different from RA, also seronegative. Can affect both peripheral joints and axial involvement (sacroilliac joints, spine). Also more patterns of onset with DIP involvement, oligoarticular, polyarticular, spondylarthritic. PsA Dactylitis and enthesitis are specific findings as opposed to RA. Iritis and nonspecific colitis can be seen as well. As in RA, treatment goals are to improve pain and function, but prevent joint destruction and disability. Medications used are the same as for RA initially, with the oral options, but some differences in biologics approved for PsA. 11
12 PsA Same concerns for medication side effects in general as well as labs and f/u. When to Refer: Inflammatory back pain in person with psoriasis alternating buttock pain, back pain at night that improves after 1 hour up in morning, back pain at night that's better with activity. Dactylitis, active joint swelling in patient with psoriasis. Don't forget to check for unusual forms of psoriasis! Osteoporosis Not an inflammatory condition, but exceedingly common in the rheumatic patient. Corticosteroid use is a big risk, but RA in particular linked to increased incidence. Consider checking DEXA's earlier than generally recommended in your rheumatic patient, especially if they are frail, smokers, strong family hx of osteoporosis or have history of what sounds like fragility fractures. Osteoporosis FRAX score tool designed to help decide when to treat ostepenia/osteoporosis. Can find online at Takes into account major risk factors and comorbidities. If a patient is on chronic corticosteroids, especially at doses > 7.5mg/day, consider initiation of bisphosphonate therapy for osteoporosis prevention. 12
13 Osteoporosis Treatments Bisphosphonate are still #1 recommended step Reclast if oral is not an option. Treatment is typically 6 years, then a break to watch for regression. If no response to bisphonsphonates, intolerance, or fractures despite tx, can move on to Prolia or Forteo. Both are injectables, Prolia is quarterly, Forteo is daily selfadministered. Osteoporosis Supplements standard recommendations for calcium and vitamin D intake include mg of calcium in a divided dose, and at least 800IU of vitamin D. Screening for vitamin D deficiency/malabsorption is recommended, as many people require more to keep level at goal. Fibromyalgia Secondary to most autoimmune disorders high levels in SLE, but also seen in RA and PsA. Felt to be due to hyperactive/sensitive nervous system. Functional PET scans and MRI's have demonstrated higher/earlier activation of pain pathways with less stimulation, but no specifics of why/how this happens have been identified. 13
14 Fibromyalgia For the most part, this is the cause of the generalized pain that many lupus and inflammatory arthritis patients report, as opposed to specific joint pains. New ACR diagnostic criteria 2010 There is no recommended blood test to identify FMS, but we do have to r/o autoimmune activity to diagnose it. Micronutrient deficiencies and thyroid disease should also be r/o. Fibromyalgia Standard treatment goals for fibromyalgia management include evaluating and working toward sound sleep so r/o sleep apnea, treating insomnia and RLS, good sleep hygeine. Best treatment for depression/anxiety, PTSD and other psychiatric conditions. Mild daily aerobic exercise, started with a slow onset and increasing as tolerated is highly recommended. 14
15 Fibromyalgia Medication options include Gabapentin, Lyrica, duloxetine, and Savella. You can use a anti-seizure med along with one of the SNRI's to cover both ascending and descending pain pathways. Muscle relaxants and NSAID's of varying benefit. Cognitive Behavioral Therapy Resources Current Rheumatology Diagnosis and Treatment, Imboden, John; Hellmann, David; Stone, John. Primer on the Rheumatic Diseases, Klippel, John; Crofford, Leslie; White, Patience, eds. Stamp, Lisa, Chapman, Peter, et al. A Randomised Controlled Trial of the Efficacy and Safety of Allopurinol Dose Escalation to Achieve Target Serum Urate in People With Gout. Annals of Rheumatic Disease, 2017;0:1-7 Tan EM, Cohen AS, Fries JF, et al. The 1982 Revised Criteria for the Classification of Systemic Lupus Erythematosus. Arthritis and Rheumatism 1982;25: Wolfe, et al. Arthritis Care and Research, Oct 1, 2010 Epub ahead of print. 15
Rheumatology Cases for the Internist
Rheumatology Cases for the Internist Marc C. Hochberg, MD, MPH Professor of Medicine Head, Division of Rheumatology and Clinical Immunology Vice Chair, Department of Medicine University of Maryland School
More informationRHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center
RHEUMATOLOGY OVERVIEW Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center What is Rheumatology? Medical science devoted to the rheumatic diseases
More information1. To review the diagnosis of gout and its differential. 2. To understand the four stages of gout
Objectives 1. To review the diagnosis of gout and its differential GOUT 2. To understand the four stages of gout 3. To develop an approach for the acute treatment of gout Anthony Lim 9/13/12 Cycle 3 4.
More informationRheumatoid arthritis and Psoriatic arthritis: a guide for Primary Care. Nina Flavin, MD Rheumatology Confluence Health April 13 th, 2018
Rheumatoid arthritis and Psoriatic arthritis: a guide for Primary Care Nina Flavin, MD Rheumatology Confluence Health April 13 th, 2018 No Disclosures Objectives Recognize early signs of RA/PsA what to
More informationRheumatoid Arthritis. Marge Beckman FALU, FLMI Vice President RGA Underwriting Quarterly Underwriting Meeting March 24, 2011
Rheumatoid Arthritis Marge Beckman FALU, FLMI Vice President RGA Underwriting Quarterly Underwriting Meeting March 24, 2011 The security of experience. The power of innovation. www.rgare.com Case Study
More informationRheumatology Review Update in Internal Medicine COPYRIGHT. Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center.
Rheumatology Review Update in Internal Medicine Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center Boston MA Case #1 True statement(s) regarding etanercept and leflunomide, for the treatment
More informationPatient #1. Rheumatoid Arthritis. Rheumatoid Arthritis. 45 y/o female Morning stiffness in her joints >1 hour
Patient #1 Rheumatoid Arthritis Essentials For The Family Medicine Physician 45 y/o female Morning stiffness in her joints >1 hour Hands, Wrists, Knees, Ankles, Feet Polyarticular, symmetrical swelling
More informationCase presentation. serum uric acid = 11.5 mg/dl 24-hour uric acid excretion = 300 mg
GOUT 55 y/o male 12 hours pain in my big toe & ankle went to bed last night feeling fine felt as if had broken toe this morning similar problems in right ankle & left wrist Case presentation lab studies
More informationGout 2.0. Scott Vogelgesang, M.D. Division of Immunology: Rheumatology & Allergy
Gout 2.0 Scott Vogelgesang, M.D. Division of Immunology: Rheumatology & Allergy Case 48 year old man presents with swollen, painful left toe that started overnight. Didn t hurt when he went to bed. No
More informationArthritis & Rheumatology Clinics of Kansas PATIENT EDUCATION SYSTEMIC LUPUS ERYTHEMATOSUS
Arthritis & Rheumatology Clinics of Kansas PATIENT EDUCATION SYSTEMIC LUPUS ERYTHEMATOSUS Introduction: There is perhaps no rheumatic disease that evokes so much fear and confusion among both patients
More informationRheumatology Updates for the Primary Care Provider
Rheumatology Updates for the Primary Care Provider Jean Tayar, MD, RhMSUS Associate Professor Section of Rheumatology and Clinical Immunology Department of General Internal Medicine UT MD Anderson Cancer
More informationMary Derlacki, FNP. No financial relationships to disclose. Office Rheumatology for the Nurse Practitioner. Rheumatoid Arthritis
Office Rheumatology for the Nurse Practitioner Mary Derlacki, FNP Drs. Cassell and Boren Eugene, OR 541-687-0816 mderlacki@comcast.net No financial relationships to disclose Rheumatoid Arthritis 1% of
More informationA Patient s Guide to Gout. Foot and Ankle Center of Massachusetts, P.C.
A Patient s Guide to Gout Welcome to Foot and Ankle Center of Massachusetts, where we believe in accelerating your learning curve with educational materials that are clearly written and professionally
More informationUnderstanding Rheumatoid Arthritis
Understanding Rheumatoid Arthritis Understanding Rheumatoid Arthritis What Is Rheumatoid Arthritis? 1,2 Rheumatoid arthritis (RA) is a chronic autoimmune disease. It causes joints to swell and can result
More informationGout A rapid review. Jeremy Jones
Gout A rapid review Jeremy Jones The Hyperuricemia Cascade Dietary purines Tissue nucleic acids Urate Endogenous purine synthesis Overproduction Hyperuricemia Underexcretion Silent tissue deposition Gout
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abatacept, for rheumatoid arthritis, 789 Acetaminophen, for low back pain, 735 Acupuncture for fibromyalgia, 753 for low back pain, 738
More information10/25/2018. Autoimmunity and how to treat it. Disclosure. Why do we get autoimmunity? James Verbsky MD/PhD Pediatric Rheumatology/Immunology
Autoimmunity and how to treat it James Verbsky MD/PhD Pediatric Rheumatology/Immunology Disclosure None I will mention drug names and some brand names but I have no financial interest or any other ties
More informationOsteoarthritis. Rheumatology Update. Gout 1/17/2013
Osteoarthritis Rheumatology Update Richard Zweig, MD January, 2013 Degeneration of cartilage over time accompanied by increase in bone density and bone formation around the joint Risks include: aging,
More informationGOUT & PSEUDOGOUT OPSC 2018 HOWARD L. FEINBERG, D.O., F.A.C.O.I.., F.A.C.R.
GOUT & PSEUDOGOUT OPSC 2018 HOWARD L. FEINBERG, D.O., F.A.C.O.I.., F.A.C.R. Everything in excess is opposed by nature Eunuchs do not take the gout, nor become bald. GOUT Hyperuricemia is not gout Gout
More informationPrior treatment with non-biologic Disease- Modifying Antirheumatic. Not to be used in combination with another biologic DMARD
Abatacept (Orencia) 1, 2, 7, 11, 13, 14, 18, 24, 31, 44, 48, 49, 51, 53, 55, 57 J0129 Alpha 1 - Proteinase inhibitor (Prolastin-C) 5, 6, 10, 12, 40 Medically Necessary (if all the following criteria apply):
More informationManaging Gout A Review of the Research for Adults
Managing Gout A Review of the Research for Adults e Is This Information Right for Me? This information is right for you if: Your health care professional* has said that you have gout. You are age 18 or
More informationUndifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD
Undifferentiated Connective Tissue Disease and Overlap Syndromes Mark S. Box, MD Overlap Syndromes As many as 25% of patients with rheumatic diseases with systemic symptoms cannot be definitely diagnosed
More informationEnhanced Primary Care Pathway: Gout
Enhanced Primary Care Pathway: Gout 1. Focused summary of gout relevant to primary care Significance: Gout is a chronic, progressive, inflammatory disease requiring appropriate long-term management. Gout
More informationWhen is it Rheumatoid Arthritis When to Refer
When is it Rheumatoid Arthritis When to Refer Nancy A. Brown, DO Spring 2015 When is it Rheumatoid Arthritis When to Refer Learning objectives To review the definition and epidemiology of Rheumatoid Arthritis
More informationCrystal induced arthropathies. Dr. Amitesh Aggarwal
Crystal induced arthropathies Dr. Amitesh Aggarwal 1 Crystal induced Arthropathies Gout Pseudogout Debilitating illnesses; Recurrent episodes of pain and joint inflammation; Formation and deposition of
More informationGOUT. Dr Krishnan Baburaj West herts NHS Trust
GOUT Dr Krishnan Baburaj West herts NHS Trust podagra Gout A disease of kings, the king of diseases History Louis XIV Emperor Augustus Henry VIII Introduction Gout an inflammatory arthritic condition that
More informationGout -revisited. Shrenik Shah
Gout -revisited Shrenik Shah definition Monosodium urate (MSU) crystal deposition episodic and later persistent joint inflammation and tophi All MSU crystal deposition- broader definition EULAR- European
More informationOBJECTIVES GOUT GOUTY INFLAMMATION 6/10/2016 GOUT INCIDENCE AND PREVALENCE MONOSODIUM URATE CRYSTAL DEPOSITION DISEASE
GOUT Lisa Talbert, MD Family Medicine Update June 15, 2016 OBJECTIVES To be familiar with the clinical presentation and pathophysiology of gouty arthritis Be able to incorporate current guidelines when
More informationAchieving Gout Goals in Your Practice An Interview with Paul P. Doghramji, MD, FAAFP
Achieving Gout Goals in Your Practice An Interview with Paul P. Doghramji, MD, FAAFP Dr. Paul Doghramji is attending physician at the Pottstown Memorial Medical Center and medical director of Health Services
More informationLupus. Fast facts. What is lupus? What causes lupus? Who gets lupus?
Lupus Systemic lupus erythematosus, referred to as SLE or lupus, is sometimes called the "great imitator." Why? Because of its wide range of symptoms, people often confuse lupus with other health problems.
More informationRheumatoid arthritis, seronegative spondylarthritides and gout. György Nagy
Rheumatoid arthritis, seronegative spondylarthritides and gout György Nagy Dec 4, 2017 Rheumatoid arthritis Rheumatoid arthritis Chronic, progressive, autoimmune disorder of the joints with extra-articular
More informationEARLY INFLAMMATORY ARTHRITIS. Cristina Tacu Consultant Rheumatologist Brighton and Sussex University Hospital
EARLY INFLAMMATORY ARTHRITIS Cristina Tacu Consultant Rheumatologist Brighton and Sussex University Hospital EIA: Introduction National priority Preventable cause of disability Very common condition High
More informationBeyond the Bowel: Extraintestinal Manifestations of Inflammatory Bowel Disease
Beyond the Bowel: Extraintestinal Manifestations of Inflammatory Bowel Disease Robert Isfort, M.D. TriHealth Digestive Institute IBD Family Education Day 2019 Learning Objectives Review manifestations
More informationDrugs Used to Treat Gout. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Drugs Used to Treat Gout Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Gout is a metabolic disease characterized by recurrent episodes of acute arthritis
More informationCoverage Criteria: Express Scripts, Inc. monograph dated 12/15/ months or as otherwise noted by indication
BENEFIT DESCRIPTION AND LIMITATIONS OF COVERAGE ITEM: PRODUCT LINES: COVERED UNDER: DESCRIPTION: CPT/HCPCS Code: Company Supplying: Setting: Kineret (anakinra subcutaneous injection) Commercial HMO/PPO/CDHP
More informationRheumatoid arthritis
Rheumatoid arthritis 1 Definition Rheumatoid arthritis is one of the most common inflammatory disorders affecting the population worldwide. It is a systemic inflammatory disease which affects not only
More informationBirthdate: / / Address: Age: Sex: M F. Telephone: H ( ) City State Zip W ( ) C ( )
Please complete this questionnaire in its entirety, even if you feel some questions may not apply to you. Our staff is available should you have any questions, or need assistance with the completion of
More informationRheumatology for the Nurse Practitioner. Mary Derlacki, FNP Eugene Rheumatology
Rheumatology for the Nurse Practitioner Mary Derlacki, FNP Eugene Rheumatology Financial Relationships Amgen Genentech AbbVie IS THIS LUPUS? S.T. is a 45 y/o woman with 9 months of joint pain, fatigue,
More informationHigh Impact Rheumatology
High Impact Rheumatology Systemic Lupus Erythematosus Bernard Rubin, DO MPH Case 1: History A 45-year-old woman presents with severe dyspnea and cough. She was in excellent health until 4 weeks ago when
More informationEtiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis
Etiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis JIA is the most common rheumatic disease in childhood and a major cause of chronic disability. Etiology: Unknown, but may
More informationDose of celecoxib in gout attack attack
Dose of celecoxib in gout attack Gout is a disease characterized by an abnormal metabolism of uric acid, resulting in an excess of uric acid in the tissues and blood. People with gout either produce too
More informationEssential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT
Essential Rheumatology Dr Ellen Bruce Consultant Rheumatologist CMFT Saving the best for last! Apparently people recall best the first and last thing they re told. Far too difficult to include everything.
More informationObjectives. Joint Pain. Case 1. Rheumatology for the Primary MD (Not just your grandmother s disease) 12/4/2010
Objectives Rheumatology for the Primary MD (Not just your grandmother s disease) Identify when it is appropriate to refer for rheumatologic evaluation Autoimmune/ Inflammatory v. noninflammatory disease
More informationMissed, Misdiagnosed & Mistreated: De-Mystifying Three Common Rheumatic Diseases
Missed, Misdiagnosed & Mistreated: De-Mystifying Three Common Rheumatic Diseases Cong-Qiu Chu, MD, PhD Assistant Professor of Medicine Oregon Health & Science University and Portland VA Medical Center
More informationGOUT IN THE ELDERLY. Learning Objectives. Disclosure. Geriatric Grand Rounds. Geriatric Grand Rounds
Visit web sites: Tuesday, June 2, 2009 12:00 noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital In keeping with Glenrose Rehabilitation Hospital policy, speakers participating in this event
More informationGout Treatment Guidelines
Gout Treatment Guidelines Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a foundation of an excess body burden of uric acid, manifested in part by hyperuricemia,
More informationAPPROACH TO PATIENTS WITH POLYARTHRALGIA
APPROACH TO PATIENTS WITH POLYARTHRALGIA Scott Vogelgesang, MD Division of Immunology University of Iowa No conflicts of interest DEFINITIONS Arthralgia joint pain with no evidence of inflammation Arthritis
More informationRheumatoid Arthritis. By: Hadi Esmaily (PharmD., BCCP, MBA) Department of Clinical Pharmacy, Shahid Beheshti Medical University
Rheumatoid Arthritis By: Hadi Esmaily (PharmD., BCCP, MBA) Department of Clinical Pharmacy, Shahid Beheshti Medical University Introduction RA is a Chronic, Systemic, Inflammatory disorder of unknown etiology
More informationPharmacological Management of Knee Pain
Pharmacological Management of Knee Pain Dr Indi Rasaratnam Consultant Rheumatologist, Epworth Health Care & The Alfred Senior Lecturer, Department of Medicine, Monash University Outline of Presentation
More informationGout: Develop treatment plan in William Jones, MS, RPh
Gout: Develop treatment plan in 2013 William Jones, MS, RPh (wnjones49@cox.net) Objectives Describe acute gouty arthritis Tx Describe Tx of chronic gouty arthritis. Define the target serum uric acid concentration
More informationACP Rheumatology Pearls. Adam Q Carlson MD Assistant Professor UVA Rheumatology
ACP Rheumatology Pearls Adam Q Carlson MD Assistant Professor UVA Rheumatology Disclosures I have no personal or professional disclosures Case #1 27 yo woman with a history of systemic lupus complicated
More informationPharmacy Prior Authorization
Pharmacy Prior Authorization AETA BETTER HEALTH PESLVAIA & AETA BETTER HEALTH KIDS Humira (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information,
More informationA CRP B FBC C LFT D blood culture E uric acid
1 A 39 year old lady with rheumatoid arthritis is admitted to hospital with a hot, swollen and painful right knee. Which is the most important blood test? A CRP B FBC C LFT D blood culture E uric acid
More informationArthritis. that affects the joints.
Arthritis that affects the joints. The word arthritis literally means inflammation of the joints. Though joint inflammation is often a symptom, rather than a specific diagnosis itself, the term arthritis
More informationPHARMACOLOGY ESSENTIALS FOR HEALTH PROFESSIONALS
Focus on PHARMACOLOGY ESSENTIALS FOR HEALTH PROFESSIONALS CHAPTER 29 Drugs Used to Treat Musculoskeletal Conditions Multimedia Directory Slide 6 Slide 25 Slide 38 Osteoporosis Video Arthritis Video Mechanism
More informationRegulatory Status FDA- approved indication: Simponi and Simponi ARIA are tumor necrosis factor (TNF) blockers indicated for the treatment of: (2-3)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.51 Subject: Simponi / Simponi ARIA Page: 1 of 9 Last Review Date: March 16, 2018 Simponi / Simponi
More informationSeronegative Arthritis. Dr Mary Gayed 25 th April 2018
Seronegative Arthritis Dr Mary Gayed 25 th April 2018 Overview Description of the conditions Discussion of symptoms & investigations that may be required Discussion of management and treatment Questions
More informationManifestations and Presentations of Collagen Vascular Diseases. Joseph LaConti, M.D., Ph.D. Center for Arthritis and Rheumatic Diseases Miami, FL
Manifestations and Presentations of Collagen Vascular Diseases Joseph LaConti, M.D., Ph.D. Center for Arthritis and Rheumatic Diseases Miami, FL June 29, 2018 Disclosures Joseph LaConti, M.D., Ph.D., has
More informationPodcast (Video Recorded Lecture Series): Gout for the USMLE Step One Exam. Howard J. Sachs, MD
Podcast (Video Recorded Lecture Series): Gout for the USMLE Step One Exam Howard J. Sachs, MD www.12daysinmarch.com Email: Howard@12daysinmarch.com Podcast (Video Recorded Lecture Series): Gout for the
More informationFIBROMYALGIA ANNE WINKLER MD PHD MO ACP MEETING SEPT 2016
FIBROMYALGIA ANNE WINKLER MD PHD MO ACP MEETING SEPT 2016 DEFINITION CHRONIC MUSCILOSKELETAL DISORDER CHARACTERIZED BY GENERALIZED PAIN AND TENDERNESS AT SPECIFIC ANATOMIC SITES. CRITERIA DEFINED IN 1990
More informationTo live with lupus, we need to know about lupus.
To live with lupus, we need to know about lupus. Zineb Aouhab, MD Assistant Professor of Medicine Loyola University Medical Center Division of Rheumatology 1 Where did the word lupus come from? The word
More informationSubject: Remicade (Page 1 of 5)
Subject: Remicade (Page 1 of 5) Objective: I. To ensure that Health Share/Tuality Health Alliance (THA) has a process by which the appropriate utilization of Remicade (Infliximab) for members whose diagnosis
More informationRheumatology Primer: What Labs and When
Rheumatology Primer: What Labs and When Irina Konon, MD Department of Internal Medicine Division of Rheumatology Medical College of Wisconsin Disclosures None 1 Objective Discuss principles of laboratory
More informationRegulatory Status FDA- approved indication: Simponi and Simponi ARIA are tumor necrosis factor (TNF) blockers indicated for the treatment of:
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.51 Subject: Simponi / Simponi ARIA Page: 1 of 8 Last Review Date: March 17, 2017 Simponi / Simponi
More informationA Patient s Guide to Psoriatic Arthritis
A Patient s Guide to Psoriatic Arthritis Glendale Adventist Medical Center 1509 Wilson Terrace Glendale, CA 91206 Phone: (818) 409-8000 DISCLAIMER: The information in this booklet is compiled from a variety
More informationLearning about Lupus. Learning About Lupus. Lupus Society of Illinois
Learning About Lupus Learning about Lupus Lupus Society of Illinois 525 W. Monroe Street, Suite 900 Chicago, Illinois 60661 Robert S. Katz, M.D. Professor of Medicine Rush University Medical Center Northwestern
More informationPennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016
Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Disclosures: Gout and Pseudogout Wayne Blount MD Speaker has no disclosures
More informationScott Vogelgesang, MD Division of Rheumatology/Immunology University of Iowa
Scott Vogelgesang, MD Division of Rheumatology/Immunology University of Iowa Basic Concepts ANA DsDNA Sm RNP SSA SSB RF/CCP ESR/CRP ANCA Cases Summary Rheumatology Tests Lie and Mislead! Rheumatology Rally
More informationWhat will happen in the future? How will gout be diagnosed? How is gout treated? prevent
Rheumatology Day Unit Dr J Hamilton 0191 4458359 0191 4455240 (9-5 Mon-Fri) Dr C Heycock 0191 4452198 Answer phone on 24hours Dr C Kelly 0191 4452193 Dr V Saravanan 0191 4456055 Dr M Rynne 0191 4458359
More informationGout. Clinical features Most commonly affects middle-aged males. It is an acute and usually relapsing selflimiting
Gout Gout is a syndrome caused by an inflammatory response to the formation of monosodium urate monohydrate crystals which develop secondary to hyperuricemia. Acute and chronic forms are recognized. Hyperuricemia
More informationBenlysta (belimumab) Prior Authorization Criteria Program Summary
Benlysta (belimumab) Prior Authorization Criteria Program Summary This prior authorization applies to Commercial, NetResults A series, NetResults F series and Health Insurance Marketplace formularies.
More informationGout- Treatment Updates. Harinder Singh, MD Rheumatology Mercy Internal Medicine Clinic Mason City, IA
Gout- Treatment Updates Harinder Singh, MD Rheumatology Mercy Internal Medicine Clinic Mason City, IA Gout Outline of purine metabolism: (1) amidophosphoribosyltransferase (2) hypoxanthine-guanine phosphoribosyltransferase
More informationAn update on the management of gout
An update on the management of gout 8 The management of gout involves treatment of an acute attack, lifestyle modification and urate lowering treatment to achieve a target serum urate level. Recent evidence
More informationImplementing AHRQ Effective Health Care Reviews Helping Clinicians Make Better Treatment Choices
Implementing AHRQ Effective Health Care Reviews Helping Clinicians Make Better Treatment Choices Gout: Diagnosis and Management Practice Pointers by MATTHEW R. NOSS, DO, MSEd, U.S. Army Health Clinic,
More informationIntroduction. Rheumatoid Arthritis. Rheumatoid Arthritis. Arthritis vs Rheumatoid Arthritis
Rheumatoid Arthritis Stuart Weisman, MD Boulder Medical Center, P.C. 303-622-3724 Introduction What is rheumatoid arthritis? How is it different than arthritis? What are the symptoms? How is it diagnosed?
More informationIs it Autoimmune or NOT! Presented to AONP! October 2015!
Is it Autoimmune or NOT! Presented to AONP! October 2015! Four main jobs of immune system Detects Contains and eliminates Self regulates Protects Innate Immune System! Epithelial cells, phagocytic cells
More informationREFERRAL GUIDELINES: RHEUMATOLOGY
Outpatient Page 1 1 REFERRAL GUIDELINES: RHEUMATOLOGY Date of birth Demographic Contact details (including mobile phone) Clinical Reason for referral Duration of symptoms Essential Referral Content Referring
More informationDevelopment of SLE among Possible SLE Patients Seen in Consultation: Long-Term Follow-Up. Disclosures. Background. Evidence-Based Medicine.
Development of SLE among Patients Seen in Consultation: Long-Term Follow-Up Abstract # 1699 May Al Daabil, MD Bonnie L. Bermas, MD Alexander Fine Hsun Tsao Patricia Ho Joseph F. Merola, MD Peter H. Schur,
More informationRheumatology Updates for Primary Care Olympic Peninsula Medical Conference. Erin M. Bauer MD Rheumatology
Rheumatology Updates for Primary Care Olympic Peninsula Medical Conference Erin M. Bauer MD Rheumatology November 2017 Objectives 1. Discuss common Rheumatology referrals and diagnoses 2. Describe initial
More informationUpdate on Gout for GPs
Update on Gout for GPs Dr Patrick Kiely PhD FRCP Consultant Physician and Rheumatologist St George s, London 2/3 1/3 Gut bacteria have uricase Chronic erosive arthropathy Clinical spectrum Making the diagnosis
More informationRheumatology GP update. Dr Mark Quinn (York) Dr Anna Moverley (SNEY) Dr Toby Wallace (Malton) November 2017
Rheumatology GP update Dr Mark Quinn (York) Dr Anna Moverley (SNEY) Dr Toby Wallace (Malton) November 2017 Aims and ambitions Rheumatology update: selected topics Service developments Local developments
More informationInflammatory rheumatic diseases
Learning objectives Inflammatory rheumatic diseases Bruce Kidd Barts & The London, Queen Mary, University of London To understand: 1. prevalence and range of the rheumatological s 2. clinical features
More informationRheumatoid Arthritis
Rheumatoid Arthritis Introduction Rheumatoid arthritis is a fairly common joint disease that affects up to 2 million Americans. Rheumatoid arthritis is one of the most debilitating forms of arthritis.
More informationRheumatology Pearls 1) A detailed history is much more useful in the work up of patients with inflammatory peripheral arthritis than any lab tests.
Rheumatology Pearls 1) A detailed history is much more useful in the work up of patients with inflammatory peripheral arthritis than any lab tests. Features suggestive of an inflammatory arthritis that
More information9/25/2013 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) 1 Other Types of Lupus Discoid Lupus Erythematosus Lupus Pernio --- Sarcoidosis Lupus Vulgaris --- Tuberculosis of the face Manifestations of SLE Fever Rashes Arthritis
More informationLecture 8 Gout Hinch. Pathogenesis of acute attacks
Gout: disease characterized by deposition of monosodium crystals in soft tissues (cartilage, tendons, bursa) recurrent episodes of acute joint pain & inflammation Pathogenesis of acute attacks Epidemiology:
More informationPalindromic rheumatism
1 What is palindromic rheumatism? The term palindromic rheumatism (also known as palindromic arthritis ) describes a form of joint pain that comes and goes in cycles or episodes, generally starting in
More informationLiving with Lupus. LFA - Georgia Gary E Myerson MD Arthritis and Rheumatology of GA
Living with Lupus LFA - Georgia Gary E Myerson MD Arthritis and Rheumatology of GA LUPUS A REALITY CHECK LUPUS A REALITY CHECK LUPUS A REALITY CHECK LUPUS A REALITY CHECK SLE 1.5 million Americans: some
More informationRheumatology Objec1ves. Rheumatology Objec1ves By the end of this presenta1on, the a<endee should be able to: 5/5/11
April 29, 2011 Presented by: Elizabeth M. Etherton, MSN, ACNP- BC, CNP Rheumatology Specialty Clinic University of New Mexico Health Science Center Rheumatology Objec1ves By the end of this presenta1on,
More informationUrate Lowering Efficacy of Febuxostat Versus Allopurinol in Hyperuricemic Patients with Gout
Philippine Journal of Internal Medicine Meta-Analysis Urate Lowering Efficacy of Febuxostat Versus Allopurinol in Hyperuricemic Patients with Gout Erika Bianca S. Villazor-Isidro, M.D.*; John Carlo G.
More informationHow to interpret and order rheumatology tests
How to interpret and order rheumatology tests Kam Shojania, MD, FRCPC Clinical Professor and Head, UBC Division of Rheumatology Faculty/Presenter Disclosure Faculty: Kam Shojania Relationships with financial
More information2. Does the patient have a diagnosis of ulcerative colitis or Crohn s? Y N
Pharmacy Prior Authorization AETA BETTER HEALTH LOUISIAA (MEDICAID) Remicade (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign
More informationwww.fisiokinesiterapia.biz Peak onset between 20 and 30 years Form of spondyloarthritis (cause inflammation around site of ligament insertion into bone) and association with HLA-B27 Prevalence as high
More informationJuvenile Idiopathic Arthritis (JIA)
Juvenile Idiopathic Arthritis (JIA) Kaveh Ardalan, MD, MS Division of Rheumatology Ann & Robert H. Lurie Children s Hospital of Chicago Assistant Professor, Pediatrics and Medical Social Sciences Northwestern
More informationEffective management of arthritis. Gail Dolan Victoria ACH Liz McIvor Stobhill ACH
Effective management of arthritis Gail Dolan Victoria ACH Liz McIvor Stobhill ACH Role Types of arthritis Drugs Self Management Role Of CNS Advanced level nurses offering specialist care in a specific
More informationJuvenileIdiopathicArthritis. Dr Johan Siebert
JuvenileIdiopathicArthritis Dr Johan Siebert 1 NORMAL DIARTHRODIAL JOINT Synovial is a thin membrane enclosing the joint space The joint space contains fluid that bathes the joint and reduces friction
More informationPsoriatic Arthritis Shared Decision Making
Psoriatic Arthritis Shared Decision Making Disease Modifying Drug Therapy DMARDs Therapy El Miedany et al. Ann Rheum Dis 74(Suppl2): 1002 DOI: 10.1136/annrheumdis-2015-eular.1410 www.rheumatology4u.com
More informationFor more information about how to cite these materials visit
Author(s): Seetha Monrad, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Noncommercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/
More informationInflammatory arthritis Shared Decision Making
Inflammatory arthritis Shared Decision Making DMARDs El Miedany et al. Ann Rheum Dis 74(Suppl2): 1002 DOI: 10.1136/annrheumdis-2015-eular.1410 www.rheumatology4u.com Copyrights reserved Contents 1 2 3
More information